A recent meta-analysis including 8,604 subjects from 30 studies identified a significant correlation between the ABCB1 C3435T polymorphism and drug-resistant epilepsy, a result that needs to be verified in a case-control study with a larger sample size, as acknowledged by the authors [45]. Here, ABCB1 is linked to epilepsy.